Respiratory Innovation Summit

Program Agenda

Hyatt Regency Orlando
9801 International Drive
Orlando, FL 32819

Friday, May 15 & Saturday, May 16

250516 181646 DK 2

Friday, May 15

11:30 a.m. Registration Desk Opens - Poster Set Up and Networking Available
12:00 p.m. Breakout Sessions (60-minute blocks in small groups- Limited to 20 seats per session)
  • VC Pitch 101 – Niall O’Donnell, PhD, MA, MBA - Managing Director, RiverVest
  • Behind the Protocol: Key Operational Insights from Clinical Trial Execution – Doreen Miao, Vice President, Marketing & Strategic Development, THORASYS
  • Talking to Industry 101 – Maria Artunduaga, MD, MPH, MTM, Founder and CEO, Samay Health
  • Recruiting Patients for Trials (Patient Advocacy) – Teresa Barnes, Chief Executive Warrior, PF Warriors
  • Logistics in Early Decision Making & Operations – Shane Krauss, Director of Strategy, Strados Labs, Inc.
  • Pre-Clinical to Phase 1 Transition – Jason Kirkness, PhD, ATSF, SMSBiotech
  • How Imaging AI is Changing the Landscape of Pharma Clinical Trials – Todd Johnson, Chief Technology Officer and Josh Schirm, Senior Director, Clinical Development from VidaLung AI
4:00 p.m. Networking Session
5:00 p.m. Networking Reception – Posters Available
6:00 p.m. Co-Chairs’ Welcoming Comments
  • Craig Conoscenti, MD, ATSF, Senior Vice President, Avalyn Pharma, Inc.
  • Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
6:10 p.m. Visionary Sponsor Address- Presented by Boehringer Ingelheim Pharmaceuticals, Inc.
6:40 p.m. Opening Showcase – Welcome to Innovation
  • Moderator Josh Fessel, MD, PhD, ATSF
  • Edesa Biotech – Par Nijhawan MD, FRCPC, AGAF, Chief Executive Officer
  • fluidIQ – Teresa Barnes, President and Co-founder
  • Inhalon Biopharma, Inc. – John Whelan, MBA, Chief Executive Officer
  • Lung Games International Inc. – Nancy Lum-Wilson B.ScPhm, MBA, Chief Executive Officer
  • TidalSense – Ameera Patel MD, PhD, Chief Executive Officer
7:10 p.m. Networking Reception and Poster Viewing
9:00 p.m. Adjourn

Saturday, May 16

7:15 a.m. Continental Breakfast – Posters Available
8:00 a.m. Welcome from the ATS President
  • Raed A. Dweik, MD, MBA, ATSF, Cleveland Clinic Health System
8:10 a.m. Co-Chair Address: State of Innovation and Investment
  • Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
  • Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
8:30 a.m. Showcase One: Breakthroughs in Critical Care
  • Moderator: Courtney Crim, MD, ATSF
  • GEn1E Lifesciences Inc. – Ritu Lal Ph.D., M.S. (Management), CEO and Co-founder
  • Herald Therapeutics – David H Ingbar, MD, Professor (UMN), Chief Scientific Officer
  • Iff Technologies – Samarth Sandeep Chief Executive Officer
  • NuvOx Therapeutics Inc. – Rong Wang President and Chief Executive Officer
  • Tessara Bio – Jahar Bhattacharya, DPhil, Scientific Co-Founder and Research Lead
9:00 a.m. Panel: Investor Discussion
  • Moderator: TBD
9:45 a.m. Networking Break – Posters Available
10:15 a.m. Showcase Two: Reimagining Chronic Respiratory Care
  • Moderator: Charles Powell, MD, MBA, Division Chief, Icahn School of Medicine
  • Altesa BioSciences, Inc. – Brett P. Giroir MD, Chief Executive Officer
  • CareCentra Inc. – Vasant Kumar Ramaswamy MBA, Founder & Chief Executive Officer
  • Kymera Therapeutics – Michael Feldman MD, PhD Executive Medical Director
  • Noze Inc. – Karim Aly, MBA, Chief Executive Officer
  • SMSbiotech – Abdulkader Rahmo, PhD, Chief Scientific Officer and Founder
10:45 a.m. Panel: Smarter Signals - How Innovative Endpoints Are Changing the Drug Development Pathway
  • Moderator: Doreen Miao, PhD, Vice President, Marketing & Strategic Development, THORASYS
  • Adam LaPrad, PhD, Chief Technology Officer, ZephyRX
  • Bina Cho, Medical Lead, Sanofi
  • Glenn Crater, MD, Chief Medical Officer, Innospera Pharma
  • Jan De Backer, PhD, Chief Executive Officer, Fluidda
11:30 a.m. Showcase Three: Cracking the Code of Lung Fibrosis
  • Moderator: Joseph Reif, MBA, Vice President, Clinical & Business Development, VIDA Diagnostics
  • Calluna Pharma – Mark Gaffney, JD, Chief Executive Officer
  • Duke Clinical Research Institute – Scott Palmer, MD, Professor of Medicine
  • MannKind Corporation – Wassim Fares, MD, MSc, Senior Vice President, Orphan Lung Therapeutic Area Head
  • Polarean – Alex Dusek Chief Business Officer
  • Sunterra Bio Inc. – Michael Hy, Founder, Chief Executive Officer
12:00 p.m. Lunch – Posters Available
1:00 p.m. Panel: Business Development
1:45 p.m. Showcase Four: Technology Transforming Respiratory Science
  • Moderator: Tom Salemi – Editorial Director, DeviceTalks
  • Cincinnati Children's Hospital – Qiwei Xiao, PhD, MSc, Research Faculty
  • Lungpacer Medical – Doug Evans, MS, MBA, Chief Executive Officer
  • O2matic – Marie-Louise Little, MSc, Chief Executive Officer
  • Qnovia, Inc. – Mario Danek, Founder, Chief Executive Officer
  • Synchrony Medical – Anat Shani, MBA, Chief Executive Officer
2:30 p.m. Networking Break – Posters Available
3:00 p.m. Showcase Five: The Emerging Science of Lung Disease
  • Moderator Ted Witek, DrPH, MBA, ATSF, Professor & Senior Fellow, University of Toronto
  • Eupnoos – Deepak Kotak MBBS, MA, Chief Medical Officer
  • Open Source Imaging Consortium (OSIC) – Elizabeth Estes, Executive Director
  • Rabble Health Inc. – Aubrey Kelly, MS, MBA, Founder and Chief Executive Officer
  • ReCode Therapeutics – John Matthews, PhD, MBBS, MRCP, Chief Medical Officer
  • RNATICS – Klaus Rabe, MD, PhD, Director of Airway Research Center North (ARCN)
3:30 p.m. RIS Featured Success Story
  • Insilico Medicine – Carol Satler MD, PhD, Senior Vice President Clinical Development
3:45 p.m. Showcase Six: The Future of Lung Health
  • Moderator: Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
  • Alveolus Bio Inc. – Ahmed Abdelgawad, MD, MS, MBA, Research Scientist, UAB
  • Synapse Biomedical Inc. – Raymond Onders MD, Chair of Surgical Innovation
  • BioNAV Environmental Health – Robert Freeman, Founder and Chief Executive Officer
  • TrilliumBiO – Aamir Ali, MD, Chief Medical Officer
  • Vicore Pharma – Ahmed Mousa, JD, MS, Chief Executive Officer
  • Generate Biomedicines – Amit Parulekar MD, MS, MBA, ATSF, Senior Director, Clinical Development
4:30 p.m. Closing Remarks and Sponsor Recognition
  • Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
  • Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
4:45 p.m. Networking Reception – Posters Available
6:00 p.m. Adjourn